I think we are also losing sight that we have other product data due in the interim....
The date to finalise whether acne results will move to Ph3 isn't until yearly next year.
We have AD results due around then. And I will bet my last $BOT that they will address these issues.... you'd think so.
This isn't the outcome I was expecting, certainly not. And some of the posts on here are raising very valid questions. I hope the AGM smoothes things over, but there will be a lot of disgruntled holders. Rightly so.
Ann: BTX 1503 Acne Phase 2 Study Results Presentation, page-444
-
- There are more pages in this discussion • 207 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.025(7.46%) |
Mkt cap ! $567.0M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 36.5¢ | 33.3¢ | $14.94M | 42.66M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 112268 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 276101 | 7 |
View Market Depth
| Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
| BOT (ASX) Chart |